Results 141 to 150 of about 15,447 (234)

Upregulation of Platelet-Activating Factor Receptor Expression and Lyso-Platelet-Activating Factor Isoforms in Human Nasal Polyp Tissues. [PDF]

J Clin Med, 2023
Roca-Ferrer J, Pérez-González M, Alobid I, Tubita V, Fuentes M, Bantulà M, Muñoz-Cano R, Valero A, Izquierdo I, Mullol J.   +9 more
europepmc   +1 more source

GATA3 Deletion Associated With Juvenile Idiopathic Arthritis: Expanding the Phenotypic Spectrum of Hypoparathyroidism, Sensorineural Deafness, and Renal Dysplasia (HDR) Syndrome

American Journal of Medical Genetics Part A, Volume 200, Issue 3, Page 733-737, March 2026.
ABSTRACT Hypoparathyroidism, sensorineural deafness, and renal dysplasia (HDR) syndrome is caused by pathogenic variants in the GATA3 gene located on chromosome 10p14. Here we present a 10‐year‐old girl with HDR syndrome who also has oligoarticular juvenile idiopathic arthritis (JIA).
Lauren N. Meiss, Amanda V. Karam, Julia Shalen, David E. Tunkel, Belina Y. Yi, Kelsey S. Guthrie, Emily M. Kudalkar, Anna E. Patrick, Sonja A. Rasmussen   +8 more
wiley   +1 more source

Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation. [PDF]

Immunity
Liao G, Nakayama T, Zhu B, Lee IT, Yeung J, Yeo YY, Chang Y, Wang C, Liao SC, Nkosi D, Renteria A, Bravo DT, Overdevest JB, Yan CH, Zarabanda D, Gall PA, Dholakia SS, Borchard NA, Yang A, Kim D, Patel ZM, Hwang PH, Wagh D, Coller J, Phillips KM, Chang MT, Lechner M, Li Z, Yeh TH, Nolan G, Longhi MS, Boussiotis V, Barouch DH, Ma Q, Nayak JV, Jiang S.   +35 more
europepmc   +1 more source

Angiomatous Nasal Polyp: The Great Emulator-A Case Report. [PDF]

Indian J Otolaryngol Head Neck Surg, 2022
Suryawanshi M, Saindani S, Bhatta S, Suryawanshi R, Sawarkar S, Bhola G.   +5 more
europepmc   +1 more source

Efficacy of Local Bupivacaine Injection of Postoperative Pain in Endoscopic Sinus Surgery

International Forum of Allergy &Rhinology, Volume 16, Issue 3, Page 231-238, March 2026.
ABSTRACT Background Regional anesthesia is effective in alleviating postoperative pain and reducing the requirement for systemic pain medications. However, optimal postoperative pain management in endoscopic sinus surgery (ESS) remains challenging.
Wiracha Leewannapasai, Navarat Tangbumrungtham, Kanokporn Sarsitthithum, Kangsadarn Tanjararak, Boonsam Roongpuvapaht   +4 more
wiley   +1 more source

Prevalence of Cystic Fibrosis Carrier Status in Chronic Rhinosinusitis Without Nasal Polyp. [PDF]

Int Forum Allergy Rhinol
Cho DY, Skelton AJ, Grayson JW, Turner JH, Woodworth BA.   +4 more
europepmc   +1 more source

Long-Term Cryopreservation of Nasal Polyp Tissue in a Biobank for the Isolation and Culture of Primary Epithelial Cells. [PDF]

Int J Mol Sci, 2023
Kim J, Hegener K, Hagedorn C, Jamal Jameel K, Weidinger D, Seuthe IMC, Eichhorn S, Kreppel F, Knobloch J, Park JJ.   +9 more
europepmc   +1 more source

Development of Artificial Intelligence for Quantitative Assessment of Nasal Inflammatory Cytology in Chronic Rhinitis by Whole‐Slide Images

International Forum of Allergy &Rhinology, Volume 16, Issue 3, Page 272-282, March 2026.
ABSTRACT Background Chronic rhinitis (CR) is currently recognized as a syndrome that manifests in different phenotypes. We aimed to establish an artificial intelligence system (quantitative assessment of nasal inflammatory cytology, QANIC) on the basis of whole‐slide images (WSIs) to enable quantitative assessment of nasal inflammatory cells.
Xu Zhang, Xu Xu, Weiwei Liu, Long Qin, Yu Song, Jingyun Li, Lin Xi, Chengshuo Wang, Luo Zhang, Yuan Zhang   +9 more
wiley   +1 more source

A Giant Encephalocele Mimicking Nasal Polyp - A Case Report. [PDF]

Indian J Otolaryngol Head Neck Surg
Tripuraneni SC, Gera S, Reddy NA.
europepmc   +1 more source

Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32‐Week Randomized Phase 1b Multiple Ascending‐Dose Trial

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 782-790, March 2026.
Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh, Chaim M. Brickman, Peter Lloyd, Ashish Kalra, Subhabrata Biswas, Arkadeep Sinha, Alex Mulvanny, Sumathi Sivapalasingam, Oren M. Becker, Aaron Deykin   +9 more
wiley   +1 more source